<TEXT>&#2;<DATELINE>2020-03-01</DATELINE><TITLE>Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial</TITLE><BODY>BackgroundThere is no proven specific pharmacological treatment for patients with the acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS remains controversial. We aimed to assess the effects of dexamethasone in ARDS, which might change pulmonary and systemic inflammation and result in a decrease in duration of mechanical ventilation and mortality.&#3;</BODY></TEXT>